COVID-19
-
July 22, 2021
Influenza network sizes up COVID
Hospital data from a CDC network that monitors influenza revealed that adults hospitalized for COVID-19 in the early months of the pandemic were 20x more likely to die compared to hospitalized influenza patients. -
July 19, 2021
Update on COVID-19 for VUMC workforce: what you need to know
COVID-19 is still very much part of our daily lives, and infection rates are on the increase in the community. VUMC continues to effectively manage COVID-19, and outpatient and inpatient volumes are back to pre-COVID levels. -
July 19, 2021
Statement from VUMC: COVID-19 vaccination continues to be the way forward
Last week, Vanderbilt University Medical Center announced that COVID-19 vaccinations for leaders will become mandatory. This was a carefully considered step forward in VUMC’s ongoing efforts to protect its patients and employees from the SARS-CoV-2 virus and its variants. -
July 9, 2021
The nurse was afraid her patient would die. She wrote her experience in a story that was shared by NPR.
Sue Perron, a Vanderbilt intensive care nurse, told the story of the patient with COVID she called the Butterfly Man -
July 8, 2021
Study finds genetic risk factors for severe COVID-19 illness
A massive worldwide collaboration including researchers from Vanderbilt University Medical Center (VUMC) has identified several genetic factors associated with SARS-CoV-2 infection and severe COVID-19 illness. -
June 23, 2021
Pediatricians see spike in RSV cases, urge parents to be on lookout for symptoms
“We are seeing a spike in respiratory illnesses, especially RSV (respiratory syncytial virus) and parainfluenza, which cause croup and bronchiolitis in young children and flu-like symptoms in older children and adults,” said James Antoon, MD, PhD, FAAP, assistant professor of Pediatrics at Children’s Hospital at Vanderbilt. -
June 22, 2021
Combination antibody therapies should retain effectiveness against emerging COVID-19 variants: study
Five monoclonal antibody “cocktails,” including one developed at Vanderbilt University Medical Center (VUMC), are protective in animal studies against several variant strains of COVID-19, according to a report this week in the journal Nature.